Tag: Cancer: Bladder
ASCO: Extended Lymph Node Removal Not Beneficial for Bladder Cancer
No benefit in terms of disease-free or overall survival seen for those with muscle-invasive bladder cancer undergoing radical cystectomy
AUA: Genomic Urine Test Accurately Predicts Bladder Cancer
Findings based on a subset of 10 genes with greatest predictive power
Urothelial Cancer Prediction Model Has High Sensitivity, Specificity
Model, which considers 10 genes from UroAmp uCGP test, had high sensitivity and specificity in two validation cohorts
Trends in Genitourinary Cancers Examined in the United States
Among non-Hispanic Whites, highest incidence rates seen in Northeast for bladder cancer, Appalachia for kidney cancer
FDA Approves Gene Therapy for Tough-to-Treat Bladder Cancer
About 57,000 men and 18,000 women are diagnosed with bladder cancer annually
Smoking Duration, Intensity Tied to Bladder Cancer Recurrence
Pipes, cigars, e-cigarettes, or marijuana not tied to recurrence risk
Nab-Paclitaxel, Pembrolizumab Combo Active in Advanced Urothelial Cancer
Overall response rate 50 percent among 36 patients with platinum-refractory or cisplatin-ineligible advanced urothelial cancer
Patients Favor Single-Port Robotic System for Uro-Oncology Surgery
Patients in the single-port versus multiport system group reported better cosmetic appearance, higher satisfaction with cosmetic appearance of surgical scar
Gemcitabine/Docetaxel Treats Nonmuscle-Invasive Bladder Cancer
Authors say Gem/Doce warrants further study for the treatment of BCG-naive high-risk non-muscle-invasive bladder cancer
Risk Stratification Examined for High-Grade Ta Bladder Tumors
For patients treated with adequate BCG, risk for BCG unresponsiveness, progression similar for all high-grade Ta tumors
